InvestorsHub Logo
Followers 275
Posts 32725
Boards Moderated 0
Alias Born 11/14/2013

Re: sukus post# 680309

Thursday, 03/21/2024 12:57:18 PM

Thursday, March 21, 2024 12:57:18 PM

Post# of 703854
Yeah, I think these chess moves were planned out further in advance than people might think. Don’t forget, in addition to NWBO getting a DCVax-Direct patent (method B+** as DocL and I like to call it) in India out to June 2036, and in addition to Mr. Sarma joining the board two days later, India is, as far as I know, the only country practicing commercial Intratumoral dendritic therapy against cancer with an Indian Company, albeit with an (arguably) less ideal product and less internationally recognized scientific support, and less internationally recognized patent, the potential symbiosis of a M@A of some sort is possible, and in addition to that, India has a closed system blood collection, leukapheresis transport system company that NWBO utilized, and probably still does. Can’t remember the name right now.

** Dr. Bosch said the “B” was for better, and DocL and I have been saying “+” because Dr. Bosch and many scientist collaborators improved the selection and narrowed manufacturing ranges since that time. Making it far more potent. They also learned how to get some suppressed patient pbmc boosted into fully functioning partially matured DCs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News